Clinical trial

Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings

NCT05614089

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-03-15

PhasePHASE4

Study timeline

Study start (actual)2023-03-15Date precision: day

Registry last updated2025-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Type 1 Diabetesunresolved

Interventions

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

NPH or premixed 70/30 (human insulin)DRUG

Sponsors & collaborators

Jing Luolead sponsor

The Leona M. and Harry B. Helmsley Charitable Trustcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05614089 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.